...
首页> 外文期刊>American Journal of Physiology >Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion.
【24h】

Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion.

机译:一氧化氮清除在血管对无细胞血红蛋白输注的反应中的作用。

获取原文
获取原文并翻译 | 示例

摘要

Modified Hb solutions have been developed as O(2) carrier transfusion fluids, but of concern is the possibility that increased scavenging of nitric oxide (NO) within the plasma will alter vascular reactivity even if the Hb does not readily extravasate. The effect of decreasing hematocrit from approximately 30% to 18% by an exchange transfusion of a 6% sebacyl cross-linked tetrameric Hb solution on the diameter of pial arterioles possessing tight endothelial junctions was examined through a cranial window in anesthetized cats with and without a NO synthase (NOS) inhibitor. Superfusion of a NOS inhibitor decreased diameter, and subsequent Hb transfusion produced additional constriction that was not different from Hb transfusion alone but was different from the dilation observed by exchange transfusion of an albumin solution after NOS inhibition. In contrast, abluminal application of the cross-linked Hb produced constriction that was attenuated by the NOS inhibitor. Neither abluminal nor intraluminal cross-linked Hb interfered with pial arteriolar dilation to cromakalim, an activator of ATP-sensitive potassium channels. Pial vascular reactivity to hypocapnia and hypercapnia was unaffected by Hb transfusion. Microsphere-determined regional blood flow indicated selective decreases in perfusion after Hb transfusion in the kidney, small intestine, and neurohypophysis, which does not have tight endothelial junctions. Administration of a NOS inhibitor to reduce the basal level of NO available for scavenging before Hb transfusion prevented further decreases in blood flow to these regions compared with NOS inhibition alone. In contrast, blood flow to skeletal and left ventricular muscle increased, and cerebral blood flow was unchanged after Hb transfusion. This cross-linked Hb tetramer is known to appear in renal lymph but not in urine. We conclude that cell-free tetrameric Hb does not scavenge sufficient NO in the plasma space to significantly affect baseline tone in vascular beds with tight endothelial junctions but does produce substantial constriction in beds with porous endothelium. The data support increasing the molecular size of Hb by polymerization or conjugation to limit extravasation in all vascular beds to preserve normal vascular reactivity.
机译:改性的血红蛋白溶液已被开发为O(2)载体输血液,但值得关注的是,即使血红蛋白不易渗出,血浆中一氧化氮(NO)清除能力的提高也会改变血管反应性。在有和没有麻醉的猫中,通过颅窗检查了通过6%癸二酰基交联四聚体血红蛋白溶液的交换输血将血细胞比容从大约30%降低到18%对具有紧密内皮连接的小动脉直径的影响。 NO合酶(NOS)抑制剂。 NOS抑制剂的灌注减少了直径,随后的Hb输注产生了额外的收缩,这与单独的Hb输注没有区别,但与NOS抑制后通过白蛋白溶液交换输注观察到的扩张不同。相反,无交联Hb的腔内应用产生的收缩被NOS抑制剂减弱。腔内或腔内交联的血红素均不干扰小动脉扩张至克罗卡林,后者是ATP敏感钾通道的活化剂。 Hb输注不会影响低碳酸血症和高碳酸血症的部分血管反应性。微球测定的区域血流表明在肾脏,小肠和神经垂体中进行Hb输注后,灌注的选择性降低,而肾垂体没有紧密的内皮连接。与单独的NOS抑制相比,在Hb输注之前给予NOS抑制剂以减少可用于清除的NO的基础水平,可防止流向这些区域的血流进一步减少。相反,输注Hb后,流向骨骼肌和左心室的血流增加,脑血流保持不变。已知这种交联的Hb四聚体出现在肾淋巴中,而不出现在尿液中。我们得出的结论是,无细胞四聚体血红蛋白不能清除血浆空间中足够的NO以显着影响具有紧密内皮连接的血管床的基线张力,但会在具有多孔内皮的床中产生实质性收缩。数据支持通过聚合或结合增加Hb的分子大小,以限制所有血管床中的渗出,从而保持正常的血管反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号